{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "adds_modification",
    "modifications" : [ {
      "position" : "Ser32",
      "modification_type" : "phosphorylation"
    } ],
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:O43318",
      "entity_text" : "TAK1",
      "entity_type" : "protein"
    },
    "is_direct" : true,
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P0CE72",
      "entity_text" : "OCM",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "The results revealed that OCM treatment yielded a marked increase in the phosphorylation of TAK1 at Ser412 and the NFkappaB target IkappaBalpha at Ser32 compared with their respective untreated controls.",
  "reading_complete" : "2020-08-02T14:09:38Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T14:07:17Z",
  "evidence" : [ "OCM treatment yielded a marked increase in the phosphorylation of TAK1 at Ser412 and the NFkappaB target IkappaBalpha at Ser32" ],
  "pmc_id" : "5835935",
  "score" : 0
}